Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain.
Frozen brain specimens from eight multiple sclerosis (MS) patients were examined for the presence of leukocytes and their cell products by using a panel of monoclonal antibodies. The results presented here demonstrated that in the MS lesion, there was a marked accumulation of HLA-Dr-positive (Ia-positive) cells. These Ia-positive cells were identified as being glial fibrillary acidic protein positive by using double staining methods. Furthermore, the cells in the MS lesion expressed the interleukin 2 (IL 2) receptor, as identified by the anti-TAC monoclonal antibody. The cells in the region of the plaque also exhibited positive staining with antibodies to IL 1, IL 2, and prostaglandin E. Neither normal brain nor brain specimens from progressive multifocal leukoencephalopathy or Alzheimer's disease showed such patterns of staining. These results suggest that stimulated cells are present in the MS brain, thus implicating an active immune mechanism in the pathogenesis of MS.
Hofman
F M
FM
von Hanwehr
R I
RI
Dinarello
C A
CA
Mizel
S B
SB
Hinton
D
D
Merrill
J E
JE
D000293:Adolescent; D000328:Adult; D000544:Alzheimer Disease / Q000276:immunology; D000911:Antibodies, Monoclonal; D000954:Antigens, Surface / Q000032:analysis*; D001253:Astrocytes / Q000032:analysis; D001921:Brain / Q000276:immunology* / Q000378:metabolism; D002452:Cell Count; D006801:Humans; D007376:Interleukin-2 / Q000378:metabolism*; D008264:Macrophages / Q000032:analysis; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000209:etiology / Q000276:immunology*; D011971:Receptors, Immunologic / Q000032:analysis*; D015375:Receptors, Interleukin-2; D013601:T-Lymphocytes / Q000032:analysis
D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D007376:Interleukin-2; D011971:Receptors, Immunologic; D015375:Receptors, Interleukin-2